BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21136795)

  • 1. Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation.
    Kobeissy FH; Sadasivan S; Oli MW; Robinson G; Larner SF; Zhang Z; Hayes RL; Wang KK
    Proteomics Clin Appl; 2008 Oct; 2(10-11):1467-83. PubMed ID: 21136795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging biomarker platforms and systems biology for rehabilomics and biologics effectiveness research.
    Kobeissy FH; Guingab-Cagmat JD; Razafsha M; O'Steen L; Zhang Z; Hayes RL; Chiu WT; Wang KK
    PM R; 2011 Jun; 3(6 Suppl 1):S139-47. PubMed ID: 21703572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroproteomics in neurotrauma.
    Ottens AK; Kobeissy FH; Golden EC; Zhang Z; Haskins WE; Chen SS; Hayes RL; Wang KK; Denslow ND
    Mass Spectrom Rev; 2006; 25(3):380-408. PubMed ID: 16498609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel neuroproteomic approaches to studying traumatic brain injury.
    Ottens AK; Kobeissy FH; Fuller BF; Liu MC; Oli MW; Hayes RL; Wang KK
    Prog Brain Res; 2007; 161():401-18. PubMed ID: 17618994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical neuroproteomics and biomarkers: from basic research to clinical decision making.
    Shoemaker LD; Achrol AS; Sethu P; Steinberg GK; Chang SD
    Neurosurgery; 2012 Mar; 70(3):518-25. PubMed ID: 21866062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation of neurological biomarkers to clinically relevant platforms.
    Hayes RL; Robinson G; Muller U; Wang KK
    Methods Mol Biol; 2009; 566():303-13. PubMed ID: 20058180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic identification of biomarkers of traumatic brain injury.
    Wang KK; Ottens AK; Liu MC; Lewis SB; Meegan C; Oli MW; Tortella FC; Hayes RL
    Expert Rev Proteomics; 2005 Aug; 2(4):603-14. PubMed ID: 16097892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroproteomics approach and neurosystems biology analysis: ROCK inhibitors as promising therapeutic targets in neurodegeneration and neurotrauma.
    Raad M; El Tal T; Gul R; Mondello S; Zhang Z; Boustany RM; Guingab J; Wang KK; Kobeissy F
    Electrophoresis; 2012 Dec; 33(24):3659-68. PubMed ID: 23161464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuroproteomics of schizophrenia.
    English JA; Pennington K; Dunn MJ; Cotter DR
    Biol Psychiatry; 2011 Jan; 69(2):163-72. PubMed ID: 20887976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of current applications of mass spectrometry for neuroproteomics in epilepsy.
    Liu X; Wen F; Yang J; Chen L; Wei YQ
    Mass Spectrom Rev; 2010; 29(2):197-246. PubMed ID: 19598206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Systems Biology in Brain Injury Biomarker Discovery: Neuroproteomics Application.
    Jaber Z; Aouad P; Al Medawar M; Bahmad H; Abou-Abbass H; Ghandour H; Mondello S; Kobeissy F
    Methods Mol Biol; 2016; 1462():157-74. PubMed ID: 27604718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translating biomarkers research to clinical care: applications and issues for rehabilomics.
    Berger RP; Houle JF; Hayes RL; Wang KK; Mondello S; Bell MJ
    PM R; 2011 Jun; 3(6 Suppl 1):S31-8. PubMed ID: 21703578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling for discovery of novel targets in human traumatic brain injury.
    Barr TL; Alexander S; Conley Y
    Biol Res Nurs; 2011 Apr; 13(2):140-53. PubMed ID: 21112922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems biology and theranostic approach to drug discovery and development to treat traumatic brain injury.
    Zhang Z; Larner SF; Kobeissy F; Hayes RL; Wang KK
    Methods Mol Biol; 2010; 662():317-29. PubMed ID: 20824479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroproteomics and Systems Biology Approach to Identify Temporal Biomarker Changes Post Experimental Traumatic Brain Injury in Rats.
    Kobeissy FH; Guingab-Cagmat JD; Zhang Z; Moghieb A; Glushakova OY; Mondello S; Boutté AM; Anagli J; Rubenstein R; Bahmad H; Wagner AK; Hayes RL; Wang KK
    Front Neurol; 2016; 7():198. PubMed ID: 27920753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of traumatic brain injury: the search for biomarkers.
    Prieto DA; Ye X; Veenstra TD
    Expert Rev Proteomics; 2008 Apr; 5(2):283-91. PubMed ID: 18466057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric research: psychoproteomics, degradomics and systems biology.
    Kobeissy FH; Sadasivan S; Liu J; Gold MS; Wang KK
    Expert Rev Proteomics; 2008 Apr; 5(2):293-314. PubMed ID: 18466058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Systems Biology to Neuroproteomics: The Path to Enhanced Theranostics in Traumatic Brain Injury.
    Jaber Z; Aouad P; Al Medawar M; Bahmad H; Abou-Abbass H; Kobeissy F
    Methods Mol Biol; 2016; 1462():139-55. PubMed ID: 27604717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of biomarkers for diagnosis and management of traumatic brain injury patients.
    Papa L; Robinson G; Oli M; Pineda J; Demery J; Brophy G; Robicsek SA; Gabrielli A; Robertson CS; Wang KK; Hayes RL
    Expert Opin Med Diagn; 2008 Aug; 2(8):937-45. PubMed ID: 23495867
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.